Related Experiment Video

Updated: Jan 31, 2026

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia
09:46

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

1.4K

Advancing management of hypertension through pharmacogenomics

Julie A Johnson1

  • 1Colleges of Pharmacy and Medicine and Center for Pharmacogenomics, University of Florida, Gainesville, Florida 100486, USA. Johnson@cop.ufl.edu

Annals of Medicine
|June 21, 2012
PubMed

Insights

Pharmacogenomics offers personalized hypertension treatment by identifying genetic biomarkers for drug response. This approach aims to improve blood pressure control rates, which are currently below 50% globally.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacogenomics
  • Genetics

Background:

  • Hypertension is a prevalent global chronic disease with suboptimal blood pressure control rates (<50%).
  • Current antihypertensive pharmacotherapy lacks individual prediction of drug efficacy, contributing to poor control.
  • Pharmacogenomics presents a promising avenue for tailoring hypertension treatment through genetic insights.

Purpose of the Study:

  • To explore the potential of pharmacogenomics in identifying genetic biomarkers for antihypertensive drug response.
  • To enhance the understanding of hypertension mechanisms and drug efficacy through genetic research.
  • To review existing evidence and future directions in hypertension pharmacogenomics.

Main Methods:

  • Review of literature on genetic polymorphisms associated with antihypertensive drug response.
  • Examination of specific gene examples such as ADRB1, CACNB2, and NEDD4L.
  • Consideration of data from recent genome-wide association studies (GWAS).

Main Results:

  • Several genes (ADRB1, CACNB2, NEDD4L) show associations between genetic polymorphisms and antihypertensive response.
  • Pharmacogenomic research is expected to yield substantial new data from ongoing GWAS.
  • Increased research collaboration is crucial for successful discoveries in large-scale studies.

Conclusions:

  • Pharmacogenomics holds significant promise for personalized antihypertensive drug selection.
  • Future research and collaboration will clarify the clinical implications of hypertension pharmacogenomics.
  • This field is expected to revolutionize hypertension management in the coming decade.

More Related Videos

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.5K
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.7K

Related Concept Videos

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
539
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
939
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
867
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
430
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups


Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.8K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K